OBJECTIVE: Previous studies revealed the relationship between stable coronary artery disease (CAD) and serum adropin level, but this relationship has not been investigated in patients with non-ST segment elevation myocardial infarction (NSTEMI). The present study is an analysis of the relationship between adropin and severity of CAD assessed based on SYNTAX score in patients with NSTEMI. METHODS: A total of 109 participants, 80 patients with NSTEMI and 29 healthy individuals, were prospectively enrolled in the study. Patients with NSTEMI were divided to 2 groups: high SYNTAX score (≥32) (35 patients) and low SYNTAX score (<32) (45 patients). Adropin level was measured from blood serum samples using enzyme-linked immunosorbent assay test. RESULTS: Patients with NSTEMI and high SYNTAX score had significantly lower serum adropin level (2357.30 pg/mL±821.58) compared to NSTEMI patients with low SYNTAX score (3077.00 pg/mL±912.86) and control group (3688.00±956.65). Adropin cut-off value for predicting high SYNTAX score on receiver-operating characteristic curve analysis was determined to be 2759 pg/mL, with a sensitivity of 63% and a specificity of 57%. Adropin was an independent predictor for high SYNTAX score (odds ratio=0.999; 95% confidence interval: 0.998-1.000; p=0.007). CONCLUSION: Adropin could be an alternative blood sample value for predicting severity of CAD.
OBJECTIVE: Previous studies revealed the relationship between stable coronary artery disease (CAD) and serum adropin level, but this relationship has not been investigated in patients with non-ST segment elevation myocardial infarction (NSTEMI). The present study is an analysis of the relationship between adropin and severity of CAD assessed based on SYNTAX score in patients with NSTEMI. METHODS: A total of 109 participants, 80 patients with NSTEMI and 29 healthy individuals, were prospectively enrolled in the study. Patients with NSTEMI were divided to 2 groups: high SYNTAX score (≥32) (35 patients) and low SYNTAX score (<32) (45 patients). Adropin level was measured from blood serum samples using enzyme-linked immunosorbent assay test. RESULTS:Patients with NSTEMI and high SYNTAX score had significantly lower serum adropin level (2357.30 pg/mL±821.58) compared to NSTEMI patients with low SYNTAX score (3077.00 pg/mL±912.86) and control group (3688.00±956.65). Adropin cut-off value for predicting high SYNTAX score on receiver-operating characteristic curve analysis was determined to be 2759 pg/mL, with a sensitivity of 63% and a specificity of 57%. Adropin was an independent predictor for high SYNTAX score (odds ratio=0.999; 95% confidence interval: 0.998-1.000; p=0.007). CONCLUSION:Adropin could be an alternative blood sample value for predicting severity of CAD.
Authors: S Savonitto; D Ardissino; C B Granger; G Morando; M D Prando; A Mafrici; C Cavallini; G Melandri; T D Thompson; A Vahanian; E M Ohman; R M Califf; F Van de Werf; E J Topol Journal: JAMA Date: 1999-02-24 Impact factor: 56.272
Authors: K Ganesh Kumar; James L Trevaskis; Daniel D Lam; Gregory M Sutton; Robert A Koza; Vladimir N Chouljenko; Konstantin G Kousoulas; Pamela M Rogers; Robert A Kesterson; Marie Thearle; Anthony W Ferrante; Randall L Mynatt; Thomas P Burris; Jesse Z Dong; Heather A Halem; Michael D Culler; Lora K Heisler; Jacqueline M Stephens; Andrew A Butler Journal: Cell Metab Date: 2008-12 Impact factor: 27.287
Authors: Sergio Raposeiras Roubín; Cristina Barreiro Pardal; Filomena Roubín-Camiña; Raymundo Ocaranza Sanchez; Ezequiel Alvarez Castro; Beatriz Paradela Dobarro; Jose María García-Acuña; Pablo Aguiar Souto; Michel Jacquet Hervet; Maria José Castromán; Isabel Arufe; Belén Outes; María Victoria Reino-Maceiras; Emad Abu Assi; José Ramón González-Juanatey Journal: Rev Port Cardiol Date: 2013-01-20 Impact factor: 1.374
Authors: David Gozal; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Helena Molero-Ramirez; Hui-Leng Tan; Hari P R Bandla Journal: J Pediatr Date: 2013-06-28 Impact factor: 4.406
Authors: C H Ramamurthy; M Suresh Kumar; V Sujatha A Suyavaran; R Mareeswaran; C Thirunavukkarasu Journal: J Food Sci Date: 2012-08 Impact factor: 3.167
Authors: Mehmet Akif Erdol; Seyma Ertem; Ahmet Goktug Ertem; Koray Demirtas; Sefa Unal; Mustafa Karanfil; Ahmet Akdi; Cagri Yayla Journal: Med Princ Pract Date: 2019-07-11 Impact factor: 1.927